Bilirubin Meters Market Size, Share, and Industry Analysis, By Product (Portable and Benchtop), By Indication (Jaundice, Hepatitis, and Others), By Age Group (Neonates and Adults), By End-user (Hospitals & Clinics, Homecare Settings, and Others), and Regional Forecast, 2025-2032

The bilirubin meters market is witnessing significant expansion owing to primary utility in neonatal and pediatric care facilities to ascertain or evaluate the predisposition to hyperbilirubinemia. These meters can also be utilized to investigate other conditions, such as blockages in the bile ducts in the liver or gallbladder.

A bilirubin meters measures and analyzes the bilirubin level in patients to help understand the severity of disease. The meters are used in jaundice and hepatitis diagnosis to identify bilirubin levels in the patients. The equipment is also utilized in healthcare settings to diagnose and monitor jaundice in newborns. Jaundice is a condition that leads to the yellowing of the skin and eyes due to high bilirubin levels. Bilirubin meters offer quick, non-invasive readings that can aid in preventing severe conditions such as kernicterus, a form of brain damage that can occur due to extremely high bilirubin levels.

• For instance, during a certain period, 2171 neonates were admitted to the NICU by the pediatric department, Faculty of Medicine, Fayoum University, Egypt, with 59.8% of them presenting with neonatal jaundice.

Due to an increase in jaundice, bilirubin levels must be checked, which propels the market expansion.

Bilirubin Meters Market Driver

Increasing Prevalence of Jaundice among Newborns to Fuel the Sales of Bilirubin Meters

The burden of jaundice has been growing significantly among newborns globally. The growing burden of jaundice is due to factors such as hypothyroidism, a condition where the livers are not fully developed and produce more bilirubin than adults. This factor has been fueling the demand for bilirubin meters for accurate diagnosis.

• According to data published by John Wiley & Sons, Inc. in June 2024, jaundice in newborns was reported between 8.9% and 60% in tertiary hospitals in Southwestern Nigeria.
• According to data published by the Ghana Hospital in May 2024, jaundice inewborns has been reported to be on the rise in the Volta Region of the country. A total of 1,238 cases were found in 2022 in Ghana.

Download Free sample to learn more about this report.

The prevalence of neonatal jaundice in South Africa was 10.4 million, in Ethiopia 8.5 million, in Bhutan 7.4 million, and in India 11.2 million in 2023.

Bilirubin Meters Market Restraint

High Meter Cost May Limit their Adoption

Bilirubin meters are very effective in detecting jaundice, especially in newborns. However, the cost of these meters may limit their sales particularly in areas with limited healthcare funding. Many healthcare facilities, especially those in developing countries, may struggle to afford expensive equipment. Within the healthcare sector, meters can also be costly, competing with other expenses such as infrastructure and workforce. Therefore, cost can be a significant challenge at times.

• For instance, the average cost of a healforce DHD-C neonatal bilirubin meter is USD 1,754.9. These products are expensive and sometimes unaffordable for individuals in low-income countries.

Bilirubin Meters Market Opportunity

Rising Infrastructure to Fuel Market Growth in the Coming Years

Due to the growing burden of jaundice and hepatitis C, especially in the developing regions, several companies have increased their focus on increasing infrastructure.

• According to data published by the National Centre for Biotechnology Information (NCBI) in March 2023, it was seen that in developed nations, the hepatitis C prevalence was ranging from 1 to 2%.
• According to data published by the National Center for Biotechnology Information (NCBI) in February 2024, clinical jaundice in the first week after birth was seen in 60% of full-term newborns and 80% of preterm newborns.

Key Insights

The report covers the following key insights:

• Prevalence/Incidence of Key Diseases, By Key Countries, 2023
• Overview: Technological Advancements in Bilirubin Meter
• Pricing Analysis, Bilirubin Meters
• New Product Launches, By Key Companies
• Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• Impact of COVID-19 on the Market

Segmentation

Analysis by Product

By product, the market is divided into portable and benchtop.

The portable devices segment accounted for a significant market share in 2023. The segment growth is attributed to its efficacy, being more convenient to use than benchtop devices and are quick and easy to perform. Transcutaneous bilirubin meters are also known as portable and present a cost-effective alternative to measuring total serum bilirubin. In the hospital setting, transcutaneous bilirubin meter contribute to a reduction in laboratory expenditures and can alleviate the time nurses spend on screening procedures. Therefore, portable devices are used as they are easily accessible due to its portability.

Analysis by Indication

By indication, the market is categorized into hepatitis, jaundice, and others.

The jaundice segment accounted for a significant market share in 2023. The growth of the segment can be attributed to an increase in hyperbilirubinemia in patients with jaundice, which causes yellow discoloration of the eyes.

• According to data published by the National Center for Biotechnology Information (NCBI) in June 2022, among the studied neonate population, the prevalence was 13.6% within the first 73 hours of life.

• According to data published by the American Journal of Tropical Medicine and Hygiene in September 2023, 6% of newborns in a semi-rural area of Kinshasa experienced hyperbilirubinemia within the first 3 days of life.

Analysis by Age Group

By age group, the market is segmented into neonates and adults.

The neonates segment accounted for a significant share of the 2023 population suffering from jaundice. The segment growth is mainly due to the increased prevalence of jaundice in newborns. Therefore, neonates suffer from jaundice more often as their livers are not mature enough to get rid of bilirubin in the bloodstream. These products are very helpful in detecting jaundice in neonates so that effective treatment can be provided.

• According to data published by Pediatric Medicine in May 2021, 35% of males and 30% of females were found to be jaundiced, out of 2,272 Nigerian infants examined daily for neonatal jaundice during the first week of life.

Analysis by End-user

By end-user, the market is segmented into homecare settings, hospitals & clinics, and others.

The hospitals and clinics segment accounted for a significant market share. The increasing number of hospital admissions for the treatment of hepatitis C and growing number of newborns in hospitals has been fueling the segment growth.

• According to data published by the journal Clinical Infectious Diseases in July 2023, the number of hospitalizations attributed to hepatitis C during the 2000-2019 period in the U.S., was estimated to be 1,286,397.

Regional Analysis

To gain extensive insights into the market, Download for Customization

By region, the market has been studied across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

The bilirubin meter treatment market in North America holds considerable share, driven by increased awareness of prevalence and distribution of jaundice. Companies based in the U.S., such as Advanced Instruments LLC and Natus Medical Incorporated, also contribute to the growing regional market.  

• According to data published by the National Center for Biotechnology Information (NCBI) in May 2023, the prevalence of jaundice in North America was 1.73%, which resulted in increased admissions for neonatal jaundice in hospitals.

Europe held a significant market share in 2023. The regional growth is due to the increased prevalence of jaundice on account of factors such as gestational age at birth, chronic medical disorders, and the mode of delivery in which bilirubin levels are identified.

Asia Pacific is considered a region with significant growth potential in the bilirubin meters market due to the increasing prevalence of jaundice in this region, particularly in countries such as China and India.

• According to data published by the National Council of Biotechnology (NCBI) in June 2023 in Asia Pacific, the prevalence of neonatal jaundice was around 3.34% in Africa and 2.58% in Southeast Asia.

The Latin America and the Middle East Africa markets also have promising growth potential due to rising healthcare expenditure and an increase in the number of patients suffering from hepatitis C. The spread of Hepatitis C is due to healthcare-related exposure and injection drug use.

• According to data published by Front Public Health in July 2023, an estimated 470,000 new HCV infections occurred in the MENA region in 2019, representing 30% of the global number of new HCV infections.

Key Players Covered

The report includes the profiles of the following key players:

• Drägerwerk AG & Co. KGaA (Germany)
• Advanced Instruments, LLC (U.S.)
• Natus Medical Incorporated (U.S.)
• Micro Lab Instruments (India)
• Mennen Medical Ltd. (Israel)
• Ginevri Srl (Italy)
• Delta Medical International (U.K.)
• Martand Medical Services (India)
• Koninklijke Philips N.V. (Netherlands)
• Das (Italy)

Key Industry Developments

• In July 2024, the Department of Pediatrics at GMC Anantnag announced that the facility has been equipped with a state of the art, transcutaneous bilirubinometers (skin bilirubin meters).
• In September 2020, Konica Minolta became Drägerwerk AG & Co. KGaA's strategic partner in promotion and academic activities for the development of jaundice meters as a legal manufacturer.